Patents by Inventor Luzheng Lisa Liu

Luzheng Lisa Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9416371
    Abstract: Attenuated, replication-deficient viruses such as vaccinia viruses are used to deliver an exogenous viral, bacterial, parastic or tumor antigen to an epidermal tissue such as the skin, lungs or gastrointestinal tract, which has been mechanically disrupted, in an amount effective to elicit or stimulate a cell mediated immune response. The epidermis may be mechanically disrupted prior to, at the same time, or immediately after the administration of the vaccine. The vaccine can be used to induce immunity against a pathogen, such as a virus, bacteria, or parasite, or against a cancer in a subject that has or is at risk of developing cancer.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: August 16, 2016
    Assignee: TremRx, Inc.
    Inventors: Thomas S. Kupper, Luzheng Lisa Liu, Rachel A. Clark
  • Publication number: 20140186298
    Abstract: Attenuated, replication-deficient viruses such as vaccinia viruses are used to deliver an exogenous viral, bacterial, parastic or tumor antigen to an epidermal tissue such as the skin, lungs or gastrointestinal tract, which has been mechanically disrupted, in an amount effective to elicit or stimulate a cell mediated immune response. The epidermis may be mechanically disrupted prior to, at the same time, or immediately after the administration of the vaccine. The vaccine can be used to induce immunity against a pathogen, such as a virus, bacteria, or parasite, or against a cancer in a subject that has or is at risk of developing cancer.
    Type: Application
    Filed: January 27, 2014
    Publication date: July 3, 2014
    Applicant: TremRx, Inc.
    Inventors: Thomas S. Kupper, Luzheng Lisa Liu, Rachel A. Clark